Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FQGTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,463
Award facts
- Contract value 100% obligated
- $19,462.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,462.69 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Dupixent—a prescription biologic used to treat conditions such as atopic dermatitis and asthma—continues AmerisourceBergen's role as a primary supplier within the DLA's global pharmaceutical network, demonstrating the company's capability to fulfill federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FQGTU?
SPE2DB25FQGTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FQGTU worth?
The government has obligated $19,463 on SPE2DB25FQGTU.
Is contract SPE2DB25FQGTU an order under another contract?
Yes. SPE2DB25FQGTU is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQGTU competed?
The extent of competition for SPE2DB25FQGTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award